Th1 and type 1 cytotoxic T cells dominate responses in T-bet overexpression transgenic mice that develop contact dermatitis

Journal of Immunology

Volumn 178, Issue 1, 2007, Pages 605-612

  Ishizaki, Kazusa ^a   Yamada, Akiko ^a   Yoh, Keigyou ^a   Nakano, Takako ^a   Shimohata, Homare ^a   Maeda, Atsuko ^a   Fujioka, Yuki ^a   Morito, Naoki ^a   Kawachi, Yasuhiro ^a   Shibuya, Kazuko ^a   Otsuka, Fujio ^a   Shibuya, Akira ^a   Takahashi, Satoru ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; TRANSCRIPTION FACTOR T BET;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTACT DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; HISTOLOGY; HYPERKERATOSIS; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTIC INFILTRATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

EID: 33845949008     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.1.605     Document Type: Article

References (37)

1. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357.
2. Romagnani, S. 1991. Human TH1 and TH2 subsets: doubt no more. Immunol. Today 12: 256-257.
3. Farrar, J. D., H. Asnagli, and K. M. Murphy. 2002. T helper subset development: roles of instruction, selection, and transcription. J. Clin. Invest. 109: 431-435.
4. Croft, M., L. Carter, S. L. Swain, and R. W. Dutton. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180: 1715-1728.
5. + T cells secreting Th1 or Th2 cytokines. Immunity 2: 271-279.
6. Glimcher, L. H., M. J. Townsend, B. M. Sullivan, and G. M. Lord. 2004. Recent developments in the transcriptional regulation of cytolytic effector cells. Nat. Rev. Immunol. 4: 900-911.
7. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
8. Sullivan, B. M., A. Juedes, S. J. Szabo, M. von Herrath, and L. H. Glimcher. 2003. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA 100: 15818-15823.
9. Lighvani, A. A., D. M. Frucht, D. Jankovic, H. Yamane, J. Aliberti, B. D. Hissong, B. V. Nguyen, M. Gadina, A. Sher, W. E. Paul, and J. J. O'Shea. 2001. T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98: 15137-15142.
10. + T cells. Nat. Immunol. 3: 549-557.
11. Kimber, I., D. A. Basketter, G. F. Gerberick, and R. J. Dearman. 2002. Allergic contact dermatitis. 2002. Int. Immunopharmacol. 2: 201-211.
12. + T cells in contact hypersensitivity and allergic contact dermatitis. Eur. J. Dermatol. 14: 131-138.
13. Kimber, I., and R. J. Dearman. 2002. Allergic contact dermatitis: the cellular effectors. Contact Dermatitis 46: 1-5.
14. Traidl, C., H. F. Merk, A. Cavani, and N. Hunzelmann. 2000. New insights into the pathomechanisms of contact dermatitis by the use of transgenic mouse models. Skin Pharmacol. Appl. Skin Physiol. 13: 300-312.
15. Hauser, C. 1990. Cultured epidermal Langerhans cells activate effector T cells for contact sensitivity. J. Invest. Dermatol. 95: 436-440.
16. Kondo, S., S. Beissert, B. Wang, H., Fujisawa, F. Kooshesh, A. Stratigos, R. D. Granstein, T. W. Mak, and D. N. Sauder. 1996. Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse. J. Invest. Dermatol. 106: 993-1000.
17. + type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165: 6783-6790.
18. + T cell-mediated contact hypersensitivity. J. Exp. Med. 189: 779-786.
19. Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis. 1995. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods 185: 133-140.
20. Yoh, K., K. Shibuya, N. Morito, T. Nakano, K. Ishizaki, H. Shimohata, M. Nose, S. Izui, A. Shibuya, A. Koyama, et al. 2003. Transgenic overexpression of GATA-3 in T lymphocytes improves autoimmune glomerulonephritis in mice with a BXSB/MpJ-Yaa genetic background. J. Am. Soc. Nephrol. 14: 2494-2502.
21. Garrigue, J. L., J. F. Nicolas, R. Fraginals, C. Benezra, H. Bour, and D. Schmitt. 1994. Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers. Contact Dermatitis 30: 231-237.
22. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34-38.
23. Snapper, C. M., and J. J. Mond. 1993. Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14: 15-17.
24. Snapper, C. M., F. D. Finkelman, and W. E. Paul. 1988. Differential regulation of IgG1 and IgE synthesis by interleukin 4. J. Exp. Med. 167: 183-196.
25. Carroll, J. M., T. Crompton, J. P. Seery, and F. M. Watt. 1997. Transgenic mice expressing IFN-γ in the epidermis have eczema, hair hypopigmentation, and hair loss. J. Invest. Dermatol. 108: 412-422.
26. Wang, L. F., J. T. Wu, and C. C. Sun. 2002. Local but not systemic administration of IFN-γ during the sensitization phase of protein antigen immunization suppress Th2 development in a murine model of atopic dermatitis. Cytokine 19: 147-152.
27. Akiyama, M., M. Yokoyama, M. Katsuki, S. Habu, and T. Nishikawa. 1993. Lymphocyte infiltration of the skin in transgenic mice carrying the human interleukin-2 gene. Arch. Dermatol. Res. 285: 379-384.
28. Turksen, K., T. Kupper, L. Degenstein, I. Williams, and E. Fuchs. 1992. Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proc. Natl. Acad. Sci. USA 89: 5068-5072.
29. Rich, B. E., J. Campos-Torres, R. I. Tepper, R. W. Moreadith, and P. Leder. 1993. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J. Exp. Med. 177: 305-316.
30. Cruz, P. D., Jr. 1996. Basic science answers to questions in clinical contact dermatitis. Am. J. Contact Dermat. 7: 47-52.
31. Lu, B., C. Ebensperger, Z. Dembic, Y. Wang, M. Kvatyuk, T. Lu, R. L. Coffman, S. Pestka, and P. B. Rothman. 1998. Targeted disruption of the interferon-γ receptor 2 gene results in severe immune defects in mice. Proc. Natl. Acad. Sci. USA 95: 8233-8238.
32. Berg, D. J., M. W. Leach, R. Kühn, K. Rajewsky, W. Müller, N. J. Davidson, and D. Rennick. 1995. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182: 99-108.
33. Asada, H., J. Linton, and S. I. Katz. 1997. Cytokine gene expression during the elicitation phase of contact sensitivity; regulation by endogenous IL-4. J. Invest. Dermatol. 108:406-411.
34. Carter, L. L., and R. W. Dutton. 1996. Type 1 and Type 2: a fundamental dichotomy for all T-cell subsets. Curr. Opin. Immunol. 8: 336-342.
35. Ting, C. N., M. C. Olson, K. P. Barton, and J. M. Leiden. 1996. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384: 474-478.
36. Zheng, W., and R. A. Flavell. 1997. The transcritpion factor GATA-3 is necessary and sufficient for Th2 Cytokine gene expression in CD4 T cells. Cell 89: 587-596.
37. Takahashi, S., L. Fossati, M. Iwamoto, R. Merino, R. Motta, T. Kobayakawa, and S. Izui. 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97: 1597-1604.